Non-invasive detection of coronary artery disease by dobutamine-stress echocardiography in children after heart transplantation

Journal of Heart and Lung Transplantation

Volumn 22, Issue 8, 2003, Pages 876-882

  Di Filippo, Sylvie ^a   Semiond, Bertrand ^a   Roriz, Ricardo ^a   Sassolas, Francois ^a   Raboisson, Marie José ^a   Bozio, André ^a  

^a LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE;

ADOLESCENT; ANGIOCARDIOGRAPHY; ARTICLE; BIOSAFETY; CALCULATION; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART CONTRACTION; HEART FUNCTION TEST; HEART LEFT VENTRICLE; HEART RATE; HEART TRANSPLANTATION; HUMAN; INFANT; INTERMETHOD COMPARISON; MALE; NEWBORN; PEDIATRICS; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RECORDING; SCORING SYSTEM; STANDARDIZATION; STATISTICAL SIGNIFICANCE; STRESS ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE;

EID: 0042165864     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00664-2     Document Type: Article

References (42)

1. Fraund S., Pethig K., Franke U., et al. Ten year survival after heart transplantation palliative procedure or successful long term treatment? Heart. 82:1999;47-51.
2. Weis M., Von Scheidt W. Cardiac allograft vasculopathy a review . Circulation. 96:1997;2069-2077.
3. Behrendt D., Ganz P., Fang J.C. Cardiac allograft vasculopathy. Curr Opin Cardiol. 15:2000;422-429.
4. Schnetzler B., Pavie A., Dorent R., et al. Heart retransplantation a 23-year single-center clinical experience . Ann Thorac Surg. 65:1998;978-983.
5. Wahlers T., Feguth H.G., Jurmann M. Graft coronary vasculopathy in cardiac transplantation - evaluation of risk factors by multivariate analysis. Eur J Cardiothorac Surg. 1:1996;1-5.
6. Park J.W., Merz M., Braun P., Vermeltfoort M. Lipid disorder and transplant coronary artery disease in long-term survivors of heart transplantation. J Heart Lung Transplant. 15:1996;572-579.
7. Sigfusson G., Fricker F.J., Bernstein D., et al. Long-term survivors of paediatric heart transplantation a multicentric report of sixty-eight children who have survived longer than five years . J Pediatr. 130:1997;862-871.
8. Michler R.E., Edwards N.M., Hsu D., et al. Paediatric retransplantation. J Heart Lung Transplant. 12:(suppl):1993;S319-327.
9. Pahl E., Zales V.R., Fricker F.J., Addonizio L.J. Posttransplant artery disease in children. A multicenter national survey. Circulation. 90:1994;II56-60.
10. Costanzo M.R., Naftel D.C., Pritzer M.R., et al. Heart transplant coronary artery disease detected by coronary angiography a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database . J Heart Lung Transplant. 17:1998;744-753.
11. Spes C.H., Klauss V., Rieber J., et al. Functional and morphological findings in heart transplant recipients with a normal coronary angiogram an analysis by dobutamine stress echocardiography, intracoronary Doppler and intravascular ultrasound . J Heart Lung Transplant. 18:1999;391-398.
12. Liang D.H., Gao S.Z., Botas J., et al. Prediction of angiographic disease by intracoronary ultra-sonographic findings in heart transplant recipients. J Heart Lung Transplant. 15:1996;980-987.
13. Mehra M.R., Ventura H.O., Jain S.P., et al. Heterogeneity of cardiac allograft vasculopathy clinical insights from coronary angioscopy . J Am Coll Cardiol. 29:1997;1339-1344.
14. Allen-Auerbach M., Schoder H., Johnson J., et al. Relationship between coronary function by positron emission tomography and temporal changes in morphology by intravascular ultrasound (IVUS) in transplant recipients. J Heart Lung Transplant. 18:1999;211-219.
15. Zhao X.M., Delbeke D., Sandler M.P., Yeoh T.K., Votaw J.R., Frist W.H. Nitrogen-13-ammonia and PET to detect allograft coronary artery disease after heart transplantation comparison with coronary angiography . J Nucl Med. 36:1995;982-987.
16. Muzik O., Duvernoy C., Beanlands R.S., et al. Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary disease by means of nitrogen-13-ammonia and positron emission tomography. J Am Coll Cardiol. 31:1998;534-540.
17. Fang J.C., Rocco T., Jarcho J., Ganz P., Mudge G.H. Non-invasive assessment of transplant-associated arteriosclerosis. Am Heart J. 135:1998;980-987.
18. Barbir M., Lazem F., Banner N., Mitchell A., Yacoub M. The prognostic significance of non-invasive cardiac tests in heart transplant recipients. Eur Heart J. 18:1997;692-696.
19. Baumgartner H., Porenta G., Lau Y.K., et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT correlation with histopathology in explanted hearts . J Am Coll Cardiol. 32:1998;1701-1708.
20. Spes C.H., Klauss V., Mudra H., et al. Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy a comparison with coronary angiography and intravascular ultrasound . Circulation. 100:1999;509-515.
21. Akosah K.O., Mohanty P.K. Role of dobutamine stress echocardiography in heart transplant patients. Chest. 113:1998;809-815.
22. Spes C.H., Mudra H., Schnaack S.D., et al. Dobutamine stress echocardiography for non invasive diagnosis of cardiac allograft vasculopathy a comparison with angiography and intravascular ultrasound . Am J Cardiol. 78:1996;168-174.
23. Derumeaux G., Redonnet M., Soyer R., Cribier A., Letac B. Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography. J Heart Lung Transplant. 17:1998;259-267.
24. Baumgartner H. Assessment of myocardial viability by dobutamine echocardiography. Acta Anesthesiol Scand. 41:1997;269-271.
25. Smart S.C., Bhatia A., Hellman R., et al. Dobutamine-atropine stress echocardiography and dipyridamole sestamibi scintigraphy for the detection of coronary artery disease limitations and concordance . J Am Coll Cardiol. 36:2000;1265-1273.
26. Poldermans D., Fioretti P.M., Boersma E., et al. Long-term prognostic value of dobutamine atropine stress echocardiography in 1737 patients with known or suspected coronary disease a single-center experience . Circulation. 99:1999;757-762.
27. Lewis J.F., Selman S.B., Murphy J.D., Mills R.M., Geiser E.A., Richard Conti C. Dobutamine echocardiography for prediction of ischemic events in heart transplant recipients. J Heart Lung Transplant. 16:1997;390-393.
28. Chuah S.C., Pellikka P.A., Roger V.L., Mc Cully R.B., Seward J.B. Role of Dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation. 97:1998;1474-1480.
29. Dhong M.R., Donnell K., Singh S., Garapati S., et al. Value of dobutamine stress echocardiography in predicting long-term cardiac events. J Am Soc Echocardiogr. 12:1999;471-475.
30. Geleijnse M.L., Fioretti P.M., Roelandt J.R. Methodology, feasability, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol. 30:1997;595-606.
31. Cortigiani L., Picano E., Coletta C., et al. Safety, feasability and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting. Am Heart J. 14:2001;621-629.
32. Pellikka P.A., Roger V.L., Oh J.K., Miller F.A., Seward J.B., Tajik A.J. Stress echocardiography. Part II. Dobutamine stress echocardiography techniques, implementation, clinical applications and correlations . Mayo Clin Proc. 70:1995;16-27.
33. Hennessy T.G., Codd M.B., Kane G., McCarthy C., McCann H.A., Sugrue D.D. Safety of dobutamine stress echocardiography in 474 consecutive studies. Coron Artery Dis. 8:1997;175-178.
34. Akosah K.O., Denlinger B., Mohanty P.K. Safety profile and hemodynamic responses to beta-adrenergic stimulation by dobutamine in heart transplant patients. Chest. 116:1999;1587-1592.
35. Pahl E., Duffy C.E., Chaudhry F.A. The role of stress echocardiography in children. Echocardiography. 17:2000;507-512.
36. Larsen R.L., Applegate P.M., Dyar D.A., et al. Dobutamine stress echocardiography for assessing coronary artery disease after heart transplantation in children. J Am Coll Cardiol. 32:1998;515-520.
37. Kimball T.R., Witt S.A., Daniels S.R. Dobutamine stress echocardiography in the assessment of suspected myocardial ischemia in children and young adults. Am J Cardiol. 79:1997;380-384.
38. Noto N., Ayusawa M., Karasawa K., et al. Dobutamine stress echocardiography for detection of coronary artery stenosis in children with Kawasaki disease. J Am Coll Cardiol. 27:1996;1251-1256.
39. Pahl E., Crawford S.E., Swenson J.M., et al. Dobutamine stress echocardiography experience in paediatric heart transplant recipients . J Heart Lung Transplant. 18:1999;725-732.
40. Kawano H., Fujii H., Motoyama T., Kugiyama K., Ogawa H., Yasue H. Myocardial ischemia due to coronary artery spasm during dobutamine stress echocardiography. Am J Cardiol. 85:2000;26-30.
41. Dent C.L., Canter C.E., Hirsch R., Balzer D.T. Transplant coronary artery disease in paediatric heart transplant recipients. J Heart Lung Transplant. 19:2000;240-248.
42. Donofrio M.T., Kakavand B., Moskowitz W.B. Evaluation of wall motion and quantitative measures of ventricular function during dobutamine stress echocardiography in paediatric cardiac transplantation patients. J Am Soc Echocardiogr. 13:2000;32-40.